Is it possible to assess subjective well-being among bipolar inpatients? An 18-week follow-up study

General Hospital Psychiatry

Volumn 33, Issue 2, 2011, Pages 185-190

  Altamura, A Carlo ^a   Porcellana, Matteo ^b   Marinaccio, Paola M ^a   Ciabatti, Maria ^a   Nocito, Emanuela P ^a   Magri, Lorenzo ^a   Bressi, Cinzia ^a  

^a UNIVERSITY OF MILAN   (Italy)

^b OSPEDALE NIGUARDA CA GRANDA   (Italy)

Author keywords

Bipolar disorder; Outcome; Quality of life; Subjective well being

Indexed keywords

ADULT; AGED; ARTICLE; BIPOLAR DEPRESSION; BIPOLAR DISORDER; BIPOLAR MANIA; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; FOLLOW UP; HAMILTON SCALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PSYCHOLOGIC ASSESSMENT; PSYCHOLOGICAL WELL BEING; YOUNG MANIA RATING SCALE;

ADULT; BIPOLAR DISORDER; FEMALE; FOLLOW-UP STUDIES; HUMANS; INTERVIEW, PSYCHOLOGICAL; ITALY; MALE; MIDDLE AGED; PERSONAL SATISFACTION; QUALITY OF LIFE;

EID: 79956049395     PISSN: 01638343     EISSN: 18737714     Source Type: Journal    
DOI: 10.1016/j.genhosppsych.2011.01.003     Document Type: Article

References (30)

1. Karow A., Czekalla J., Dittmann R.W., et al. Association of subjective well-being, symptoms, and side effects with compliance after 12 months of treatment in schizophrenia. J Clin Psychiatry 2007, 68(1):75-80.
2. Naber D. Subjective effects of antipsychotics drugs and their relevance for compliance and remission. Epidemiol Psichiatr Soc 2008, 17:174-176.
3. Schimmelmann B.G., Moritz S., Karow A., et al. Correlates of subjective well-being in schizophrenic patients treated with atypical antipsychotics. Int J Psychiatr Clin Psychiatry 2005, 9:94-98.
4. Hellewell J. Patients' subjective experiences of antipsychotics. Clinical relevance. CNS Drugs 2002, 16:457-471.
5. Voruganti L., Cortese L., Oyewumi L., et al. Comparative evaluation of conventional and novel antipsychotic drugs with reference to their subjective tolerability, side-effect profile and impact of quality of life. Schizophr Res 2000, 43:135-145.
6. Van Os J., Altamura A.C., Bobes J., et al. 2-COM: an instrument to facilitate patient-professional communication in routine clinical practice. Acta Psychiatr Scand 2002, 106(6):446-452.
7. Naber D., Moritz S., Lambert M., et al. Improvement of schizophrenic patients' subjective well-being under atypical antipsychotic drugs. Schizophr Res 2001, 50:79-88.
8. Voruganti L., Heslegrave R., Awad A., Seeman M.V. Quality of life measurement in schizophrenia: reconciling the quest for subjectivity with the question of reliability. Psychol Med 1998, 28:165-172.
9. Balestrieri M., Giaroli G., Mazzi M., Bellantuono C. Performance of the Italian version of the subjective well-being under neuroleptic (SWN) scale in schizophrenic outpatients. Pharmacopsychiatry 2006, 39:81-84.
10. Lambert M., Schimmelmann B.G., Naber D., et al. Predict of remission as a combination of symptomatic and functional remission and adequate subjective well-being in 2960 patients with schizophrenia. J Clin Psychiatry 2006, 67:1690-1697.
11. Lambert M., Naber D., Eich F.X., et al. Remission of severely impaired subjective wellbeing in 727 patients with schizophrenia treated with amisulpride. Acta Psychiatr Scand 2007, 115:106-113.
12. Schennach-Wolff R., Jager M., Obermeier M., et al. Quality of life and subjective well-being in schizophrenia and schizophrenia spectrum disorders: valid predictors of symptomatic response and remission. World J Biol Psychiatry 2010, 11(5):729-738.
13. Wehemeier P.M., Kluge M., Schacht A., Helsberg K., Schreiber W. Correlation of physician and patient rated quality of life during antipsychotics treatment in outpatients with schizophrenia. Schizoph Res 2007, 91:178-186.
14. Kim J.H., Ann J.H., Kim M.J. The relationship between depressive symptoms and subjective well-being in newly admitted patients with schizophrenia. Compr Psychiatry 2010, 51:165-170.
15. Pollice R., Tomassini A., Malavolta M., et al. Subjective and psychopathological response in patients under different antipsychotic treatment: are there differences in real clinical practice?. J Biol Regul Homeost Agents 2008, 22:83-91.
16. Lambert M., Naber D., Karow A., et al. Subjective wellbeing under quetiapine treatment: effect of diagnosis, mood state and anxiety. Schizophr Res 2009, 110:72-79.
17. Altamura A.C., Armadoros D., Jaeger M., et al. Importance of open access to atypical antipsychotics for the treatment of schizophrenia and bipolar disorder: a European perspective. Curr Med Res Opin 2008, 24(8):2271-2282.
18. First M.B., Gibbon M., Spitzer R.L., Williams J.B. User guide for the Structural Clinical Interview for DSM-IV (SCID) Axis I Disorders 1996, American Psychiatry Association, Washington DC.
19. Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry 1960, 23:56-62.
20. Young R., Biggs J., Meyer D.A. A rating scale for mania: reliability, validity and sensitivity. Br J Psychiatry 1978, 133:429-435.
21. Spearing M.K., Post R.M., Leverich G.S., Brandt D., Nolein W. Modification of the Clinical Global Impressions (CGI) scale for use in bipolar illness (BP): the CGI-BP. Psychiatry Res 1997, 73:159-171.
22. Hirshfield R. Guideline watch for the practice guideline for the treatment of patients with bipolar disorder 2005, American Psychiatric Association, Arlington, VA.
23. Kebede D., Alem A., Shibire T., Deyassa N., Negash A., Beyero T., et al. Symptomatic and functional outcome of bipolar disorder in Butajira, Ethiopia. J Affect Disord 2006, 90:239-249.
24. Huppert J.D., Weiss K.A., Lim R., Pratt S., Smith T.E. Quality of life in schizophrenia: contributions of anxiety and depression. Schizophr Res 2001, 51:171-180.
25. Hofer A., Kemmler G., Eder U., Edlinger M., Hummer M., Fleischacker W.W. Quality of life in schizophrenia: the impact of psychopathology, attitude toward medication, and side effects. J Clin Psychiatry 2004, 65:932-939.
26. Hansson L. Determinants of quality of life in people with severe mental illness. Acta Psychiatr Scan Supp 2006, 429:46-50.
27. Narvaez J.M., Twamley E.W., McKibbin C.L., Heaton R.K., Petterson T.L. Subjective and objective quality of life in schizophrenia. Schizophr Res 2008, 98:201-208.
28. Sim K., Mahendran R., Siris S.G., Heckers S., Chong S.A. Subjective quality of life in first episode schizophrenia spectrum disorders with comorbid depression. Psychiatry Res 2004, 129:141-147.
29. Fleischacker W.W., Rabinowitz J., Kemmler G., Eerdekens M., Mehnert A. Perceived functioning, well-being and psychiatric symptoms in patients with stable schizophrenia treated with long-acting risperidone for 1 year. Br J Psychiatry 2005, 187:131-136.
30. Galletly C.A., Clark C.R., McFarlane A.C., Weber D.L. Relationships between changes in symptom ratings, neuropsychological test performance and quality of life in schizophrenia patients treated with clozapine. Psychiatry Res 1997, 72:161-166.